Literature DB >> 30599284

Pathogen reservoir hypothesis investigated by analyses of the adenotonsillar and middle ear microbiota.

James Johnston1, Michael Hoggard2, Kristi Biswas3, Carmen Astudillo-García2, Fiona J Radcliff4, Murali Mahadevan3, Richard G Douglas3.   

Abstract

INTRODUCTION: Adenotonsillar and middle ear diseases result in some of the most frequently performed operations in the pediatric population worldwide. The pathogen reservoir hypothesis (PRH) suggests that the adenoids act as a reservoir of bacteria which play a potential pathogenic role in otitis media. Evidence supporting this hypothesis is limited. This study sought to comprehensively determine and compare associations between the adenotonsillar and middle ear bacterial microbiota within individual patients via next-generation sequencing and microbial network analyses.
METHODS: Bacterial 16S rRNA gene-targeted amplicon sequencing was used to determine the bacterial composition of ten pediatric patients undergoing adenotonsillectomy and ventilation tube insertion for otitis media with effusion. At the time of surgery, swabs were taken from the adenoid surface, tonsil crypts and middle ear clefts (through the myringotomy incision).
RESULTS: The most abundant sequences within the bacterial community at genus level across all anatomical sites were Fusobacterium, Haemophilus, Neisseria, and Porphyromonas. There was an observable difference in the relative abundance of bacterial communities, with a higher proportion of Haemophilus and Moraxella in the adenoid when compared with the middle ear. Furthermore, only one module (consisting of 4 bacterial OTUs) from one patient was identified through microbial network analyses to be significantly associated between middle ear and adenoid. In addition, microbial network analysis revealed that the adenoid and tonsil microbiota share greater similarity than do the adenoid and middle ear.
CONCLUSION: The results of this study suggest that the adenoid microenvironment does not correlate to the middle ear microenvironment. A future study at the species level, and over time, is required to further investigate whether the differing relationship between the microbiota of the adenoid and middle ear rejects the pathogen reservoir hypothesis.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  16s rRNA sequencing; Adenoid; Microbiome; Middle ear; Pathogen reservoir hypothesis; Tonsil

Mesh:

Substances:

Year:  2018        PMID: 30599284     DOI: 10.1016/j.ijporl.2018.12.030

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  10 in total

1.  Analysis of the Microbiome in the Adenoids of Korean Children with Otitis Media with Effusion.

Authors:  Sung Kyun Kim; Seok Jin Hong; Kyung Ho Pak; Seok Min Hong
Journal:  J Int Adv Otol       Date:  2019-12       Impact factor: 1.017

Review 2.  Translating Recent Microbiome Insights in Otitis Media into Probiotic Strategies.

Authors:  Marianne F L van den Broek; Ilke De Boeck; Filip Kiekens; An Boudewyns; Olivier M Vanderveken; Sarah Lebeer
Journal:  Clin Microbiol Rev       Date:  2019-07-03       Impact factor: 26.132

Review 3.  Review of otitis media microbiome studies: What do they tell us?

Authors:  Juan Carlos Nogues; Marcos Pérez-Losada; Diego Preciado
Journal:  Laryngoscope Investig Otolaryngol       Date:  2020-09-21

4.  Comparative Analysis of Microbiome in Nasopharynx and Middle Ear in Young Children With Acute Otitis Media.

Authors:  Qingfu Xu; Steve Gill; Lei Xu; Eduardo Gonzalez; Michael E Pichichero
Journal:  Front Genet       Date:  2019-11-19       Impact factor: 4.599

Review 5.  Recent Perspectives on Gene-Microbe Interactions Determining Predisposition to Otitis Media.

Authors:  Rahul Mittal; Sebastian V Sanchez-Luege; Shannon M Wagner; Denise Yan; Xue Zhong Liu
Journal:  Front Genet       Date:  2019-11-26       Impact factor: 4.599

6.  Sleep Disordered Breathing and Recurrent Tonsillitis Are Associated With Polymicrobial Bacterial Biofilm Infections Suggesting a Role for Anti-Biofilm Therapies.

Authors:  Tulia Mateus; Elke J Seppanen; Camilla de Gier; Sharon Clark; Harvey Coates; Shyan Vijayasekaran; Karen Prosser; Selma P Wiertsema; Angela Fuery; Lea-Ann S Kirkham; Peter C Richmond; Ruth B Thornton
Journal:  Front Cell Infect Microbiol       Date:  2022-02-28       Impact factor: 5.293

7.  Microbiota Associated With Cholesteatoma Tissue in Chronic Suppurative Otitis Media.

Authors:  Daniel N Frank; Jose Pedrito M Magno; Karen Joyce S Velasco; Tori C Bootpetch; Jacob Ephraim D Salud; Kevin Jer V David; Aaron L Miller; Eljohn C Yee; Heather P Dulnuan; Richard B Pyles; Jan Alexeis C Lacuata; Jeric L Arbizo; Jennifer M Kofonow; Beatrice Guce; Kevin Michael D Mendoza; Charles E Robertson; Gabriel Martin S Ilustre; Alessandra Nadine E Chiong; Shi-Long Lu; Erik A Tongol; Nicole D Sacayan; Talitha Karisse L Yarza; Charlotte M Chiong; Regie Lyn P Santos-Cortez
Journal:  Front Cell Infect Microbiol       Date:  2022-04-19       Impact factor: 6.073

8.  Mucosal immune cell populations and the bacteriome of adenoids and tonsils from people living with HIV on suppressive antiretroviral therapy.

Authors:  Olivia Briceño; Mauricio Gónzalez-Navarro; Nadia Montufar; Monserrat Chávez-Torres; Indira Abato; Ariana Espinosa-Sosa; Yuria Ablanedo-Terrazas; Yara Luna-Villalobos; Santiago Ávila-Ríos; Gustavo Reyes-Terán; Sandra Pinto-Cardoso
Journal:  Front Microbiol       Date:  2022-08-11       Impact factor: 6.064

Review 9.  Reviewing the Pathogenic Potential of the Otitis-Associated Bacteria Alloiococcus otitidis and Turicella otitidis.

Authors:  Rachael Lappan; Sarra E Jamieson; Christopher S Peacock
Journal:  Front Cell Infect Microbiol       Date:  2020-02-14       Impact factor: 5.293

10.  Identification of the Bacterial Pathogens in Children with Otitis Media: A Study in the Northwestern Portuguese District of Braga.

Authors:  Maria Daniela Silva; António Lima; Nuno Marçal; Luís Dias; Miguel Gama; Sanna Sillankorva
Journal:  Microorganisms       Date:  2021-12-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.